Analysis of B-Myb expression in the context of various clinicopathologic features revealed that the expression level of B-Myb mRNA was positively correlated with pathologic grade (p = 0.005), clinical stage (p < 0.05), and tumor-node-metastasis (TNM) classification (p < 0.01; Figure 1A). The gene discussed is MYBL2; the disease is neoplasm.